Pdt Partners, LLC Xeris Biopharma Holdings, Inc. Transaction History
Pdt Partners, LLC
- $1.28 Billion
- Q1 2025
A detailed history of Pdt Partners, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 239,600 shares of XERS stock, worth $1.18 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
239,600Holding current value
$1.18 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
204Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$51 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$40.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$21.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$16.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $672M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...